ViiV

CABENUVA

Manufacturer:

ViiV

Cabenuva HCPCS:

J0741

HCPCS Code Descriptor:

Injection, cabotegravir and rilpivirine, 2mg/3mg

Category:

J Code

Cabenuva NDCs:

49702-0240-15, 49702-0253-15

Primary Type:

Anti-HIV

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intramuscular

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Cabenuva:

CABENUVA is an Anti-HIV drug manufactured by ViiV and administered via the Intramuscular route of administration. The J Code: J0741 is aligned to the drug CABENUVA.

ACCESS PRICING AND MORE BY REGISTERING

J0741 Added Date:

October 1, 2021

J0741 Effective Date:

October 1, 2021

J0741 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cabenuva billing and coding information.
Cabenuva patient assistance information can be found through ViiVConnect at the URL: https://www.viivconnect.com/
CABENUVA prescribing information can be found at the link below:
Information regarding CABENUVA’s side effects can be found at MedlinePlus